Search

everythinglearnresearchcommunity

for

Search:↓

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Both mouse and rat models are effective for testing alopecia areata treatments.

Nivolumab can cause hair loss as a rare side effect.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Six genetic conditions are often linked to complete scalp hair loss in children.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.